Available On-Demand

Monoclonal gammopathies of undetermined significance (MGUS) is a widespread phenomenon that increases markedly with age. While MGUS itself requires no medical action, the risk it poses for developing a blood cancer such as multiple myeloma (MM) is 1% per year. Detection and monitoring of MGUS are therefore critical to ensure early discovery of progression to MM. This is important because the earlier MM is treated, the better the chances of curing the disease.

This webinar highlights the key role of free light chain (FLC) testing in the detection and monitoring of MGUS and summarizes the results of recent studies.

Key learning objectives

  • Understand when serum FLC (sFLC) should be utilized in MGUS diagnosis
  • Find out how sFLC assessment is incorporated in risk stratification of MGUS
  • Learn how to incorporate sFLC in monitoring of MGUS

Who should attend

  • Endocrinologists
  • Hematologists
  • Hematologist-oncologists
  • Hemopathologists
  • Intensive care physicians
  • Nephrologists
  • Oncologists

Accreditation statement

SelectScience is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program.

Presenters

Dr. Charlotte Gran
Dr. Charlotte Gran

Center for Hematology and Regenerative Medicine (HERM),

Department of Medicine, Karolinska Institute, Stockholm, Sweden

Dr. Charlotte Gran is a distinguished attending specialist in clinical chemistry, with a primary responsibility for routine hematology at Karolinska University in Stockholm, Sweden. She also lectures on the laboratory aspects of hematology at the same institution. Dr. Gran is engaged in pioneering research, with a particular interest in the dynamic changes in peripheral biomarkers in the premalignant stages, such as MGUS and smoldering multiple myeloma (SMM) to identify patients who might benefit the most from intervention and those at the highest risk of progression. Dr. Gran's contributions are underlined by a portfolio of over 20 peer-reviewed publications, as first author and as a co-author.

Dora Wells
Dora Wells

Editorial Team

SelectScience

Dora studied biomedical science at the University of Manchester, UK, and as a member of the editorial team, plays an integral role in helping to shape the content on SelectScience.

Register

Note: By completing this form, you will receive a free membership to SelectScience® and The Scientists’ Channel®. SelectScience is a trade organisation, we do not provide services to consumers and membership is for business purposes only. As a member you must provide us with a corporate email address to enable us (and our advertisers and sponsors) to contact you for marketing purposes. You can opt-out of marketing at any time. See our Privacy Policy

(*) denotes required form field(s)

Our registration process uses cookies, by submitting this registration form you agree to our cookie policy.

* Required Fields